Bone marrow-derived mesenchymal stem cells for ischemic stroke: mechanisms, delivery strategies, clinical evidence, and translational challenges.

Zhang W, Xu H, Guo F, Zhang Z, Liu W

Open source

DOI
10.1186/s13287-026-05219-7
Published
2026 Aug 8
Container
Stem cell research & therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13287-026-05219-7,
  title = {Bone marrow-derived mesenchymal stem cells for ischemic stroke: mechanisms, delivery strategies, clinical evidence, and translational challenges.},
  author = {Zhang W and Xu H and Guo F and Zhang Z and Liu W},
  year = {2026},
  journal = {Stem cell research \& therapy},
  doi = {10.1186/s13287-026-05219-7},
  url = {https://doi.org/10.1186/s13287-026-05219-7}
}

RIS

TY  - JOUR
TI  - Bone marrow-derived mesenchymal stem cells for ischemic stroke: mechanisms, delivery strategies, clinical evidence, and translational challenges.
AU  - Zhang W
AU  - Xu H
AU  - Guo F
AU  - Zhang Z
AU  - Liu W
PY  - 2026
JO  - Stem cell research & therapy
DO  - 10.1186/s13287-026-05219-7
UR  - https://doi.org/10.1186/s13287-026-05219-7
ER  - 

APA

W, Z., H, X., F, G., Z, Z., & W, L. (2026). Bone marrow-derived mesenchymal stem cells for ischemic stroke: mechanisms, delivery strategies, clinical evidence, and translational challenges.. Stem cell research & therapy. https://doi.org/10.1186/s13287-026-05219-7

Source records